Search Results - "Guérois, C."

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients by LAMBERT, T., GUÉROIS, C., GAY, V., STIELTJES, N., BERTRAND, M.-A., DERLON, A., SIGAUD, M., HASSOUN, A., NÉGRIER, C., COATMELEC, B., DREYFUS, M., DUBANCHET, A.

“…A recent multicentre collaborative study showed higher estimates of ReFacto® potency when assayed with ReFacto Laboratory StandardTM (RLS) in comparison when…”
Get full text

French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy by Meunier, S, Trossaërt, M, Berger, C, Borel-Derlon, A, Dirat, G, Donadel-Claeyssens, S, Assolant, A Durin, Guérois, C, Lutz, P, Rafowicz, A, Rothschild, C, Chambost, H

“…During the last decades, long-term prophylaxis has become the gold standard for the treatment of children with severe haemophilia A or B. Prophylactic…”
Get full text

Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors by d’Oiron, Roseline, Volot, F., Reynaud, J., Peerlinck, K., Goudemand, J., Guérois, C., Rothschild, C., Chambost, H., Borel-Derlon, A., Roussel-Robert, V., Marquès-Verdier, A., Lienhart, A., Berthier, A.M., Moreau, P., Lambert, T.

“…Patients with mild/moderate hemophilia A (MHA) may develop inhibitors to factor VIII (FVIII). In this condition, FVIII clotting activity (FVIII:C) baseline…”
Get full text

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate by Guérois, C, Laurian, Y, Rothschild, C, Parquet-Gernez, A, Duclos, A M, Négrier, C, Vicariot, M, Fimbel, B, Fressinaud, E, Fiks-Sigaud, M

“…The incidence of factor VIII inhibitor was studied in a cohort of 56 previously untreated patients with severe hemophilia A (factor VIII below 1 U/dl). They…”
Get more information

A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate by Goudemand, J, Peynet, J, Chambost, H, Négrier, C, Briquel, M E, Claeyssens, S, Derlon-Borel, A, Guérois, C, Caron, C, Scherrmann, J M, Debray, M, Bridey, F

“…A double blind randomized cross-over multi-center study has been conducted to compare the pharmacokinetic and coagulation activation markers of high-purity…”
Get more information

Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate by Parquet, A, Laurian, Y, Rothschild, C, Navarro, R, Guérois, C, Gay, V, Durin, A, Peynet, J, Sultan, Y

“…Fifteen previously untreated patients (Pups) with severe haemophilia B (factor IX activity < or = 2 U/dl) only treated with one brand of plasma-derived high…”
Get more information

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders by Doncarli, Alexandra, Demiguel, Virginie, Canu, Irina Guseva, Goulet, Véronique, Bayart, Sophie, Calvez, Thierry, Castet, Sabine, Dalibard, Vincent, Demay, Yohan, Frotscher, Birgit, Goudemand, Jenny, Lambert, Thierry, Milien, Vanessa, Oudot, Caroline, Sannié, Thomas, Chambost, Hervé

“…FranceCoag is an ongoing open prospective multicentre cohort project aimed at improving epidemiological knowledge about inherited bleeding disorders in France…”
Get full text

French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance by Rothschild, C, Laurian, Y, Satre, E P, Borel Derlon, A, Chambost, H, Moreau, P, Goudemand, J, Parquet, A, Peynet, J, Vicariot, M, Beurrier, P, Claeyssens, S, Durin, A, Faradji, A, Fressinaud, E, Gaillard, S, Guérin, V, Guérois, C, Pernod, G, Pouzol, P, Schved, J F, Gazengel, C

“…Fifty French previously untreated patients with severe hemophilia A (factor VIII < 1%), treated with only one brand of recombinant factor VIII (rFVIII), were…”
Get more information

Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working group by WINTZ, L., SANNIÉ, T., AYÇAGUER, S., GUEROIS, C., BERNHARD, J. -P., VALLUET, D., BOREL-DERLON, A., GUILLON, P., FONDANESCHE, C., LAMBERT, T., MEUNIER, S., ALLIAUME, N., GAGNAYRE, R.

“…The activities of ‘expert patients’ or ‘patient tutors’, who help educate their peers, are gaining recognition in the health care system. This study…”
Get full text

Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216) by Leroy, J, Leclerc, M H, Delahousse, B, Guérois, C, Foloppe, P, Gruel, Y, Toulemonde, F

“…This report concerns 34 cases of heparin-associated thrombocytopenia in which standard heparin has been systematically replaced by LMW heparin CY 216 Choay…”
Get more information

Hepatitis A in French hemophiliacs by Goudemand, J, Parquet, A, d'Oiron, R, Stieltjes, N, Guérois, C, Fonlupt, J, Alcalay, M, Négrier, C, Cazenave, J P, Briquel, M E

“…The prevalence of serum antibodies to hepatitis A virus (HAV) in 793 hemophilia A (HA) and 89 hemophilia B (HB) patients coming from 10 French Hemophilia…”
Get more information

Acquired inhibitor to factor VIII in a patient with Hodgkin’s disease following treatment with interferon‐alpha by Regina, S., Colombat, P., Fimbel, B., Guerois, C., Gruel, Y.

“…We describe a young woman who developed acquired haemophilia after 18 months of interferon (IFN‐)‐α therapy. This patient had been monitored since 1992 for…”
Get full text

The Kinetics of Antibodies against Hepatitis C Virus May Predict Viral Clearance in Exposed Hemophiliacs by Lanotte, Philippe, Dubois, Frédéric, Le Pogam, Sophie, Guerois, Claude, Fimbel, Béatrice, Bacq, Yannick, Gruel, Yves, Goudeau, Alain, Barin, Francis

“…Several studies have reported the spontaneous loss of hepatitis C virus (HCV) antibodies in HCV-exposed persons. However, the relationship between…”
Get full text

Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations by FRANCOIS, M, DUBOIS, F, BRAND, D, BACQ, Y, GUEROIS, C, MOUCHET, C, TICHET, J, GOUDEAU, A, BARIN, F

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study by Fiks-Sigaud, M, Bendelac, L, Parquet, A, Verroust, F, Torchet, M F, Berthier, A M, Fressinaud, E, Guerois, C, Aillaud, M F, Boneu, B

“…The levels of anti-human and anti-porcine factor VIII inhibitors, measured in 63 severe haemophilia A patients, lay in the ranges of < 0.2-2,600 and <…”
Get more information

Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success by Mariani, G, Kroner, B, Immune Tolerance Study Group (ITSG)

“…Hematology and BMT Unit, Palermo University Hospital, Italy. guglielmo.mariani@tin.it BACKGROUND AND OBJECTIVES: Long term administration of high doses of…”
Get full text

INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B by Pouplard, C., Lequerrec, A., Trossaert, M., Delahousse, B., Guerois, C., Giraudeau, B., Gruel, Y.

Get full text

The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT) (26 cases) by Benhamou, A C, Gruel, Y, Barsotti, J, Castellani, L, Marchand, M, Guerois, C, Leclerc, M H, Delahousse, B, Griguer, P, Leroy, J

“…The Authors report a new iatrogenic complication of preventive or curative standard heparinotherapy. This so called "white clot syndrome" or "Heparin…”
Get more information

Incidence des inhibiteurs anti-F VIII chez des patients traités par FACTEUR VIII-LFB by GOUDEMAND, J, D'OIRON, R, BRIQUEL, M.-E, DERLON, A, FIKS-SIGAUD, M, FRESSINAUD, E, GAILLARD, S, ROTHSCHILD, C, PARQUET, A, GEMBARA, P, CLAEYSSENS, S, GUEROIS, C, VICARIOT, M, BERTHIER, A.-M, BEURRIER, P

Get full text

Le FACTEUR IX-LFB® : Expérience en chirurgie by CLAEYSSENS, S, PEYNET, J, STIELTJES, N, SULTAN, Y, BRIDEY, F, GOUDEMAND, J, GAZENGEL, C, ALCALAY, M, BERTRAND, M.-A, BRIQUEL, M.-E, DERLON, A, GUEROIS, C, D'OIRON, R, PAUTARD, B

Get full text